SENTRY/Emerging Drug Tracking System

Forms and Documents

Document Name	Status
Form 1105-xxxx SENTRY/Emerging Drug Tracking System Form and Instruction	New
Public Law_LEXSEE 102 PL 396.rtf Supplementary Document	2007-07-24
Sentry SUPPORTING STATEMENT_Addendum_101607 (3).doc Supporting Statement A	2007-10-16

IC Document Collections

IC ID	Document Title	Status
181248	SENTRY/Emerging Drug Tracking System Form and Instruction	New

ICR Details

OMB Control No: 1105-0087	ICR Reference No: 200707-1105-001
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: DOJ/LA	Agency Tracking No:
Title: SENTRY/Emerging Drug Tracking System
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 10/23/2007
	Date Received in OIRA: 07/24/2007
Terms of Clearance: DOJ will provide updates to OMB regarding the implementation of SENTRY. Specifically, it will report on the effectiveness of the program to mitigate the impact of synthetic drugs in the US. Going forward, DOJ will also provide detailed information on who is using the information, and what they are using it for.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	10/31/2010	36 Months From Approved
Responses	300	0	0
Time Burden (Hours)	75	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: SENTRY/Emerging Drug Tracking System is an internet-based collection and dissemination system designed to help identify new syntetic drug-related behaviors at an early stage, evaluate their importance, and track their development. The ultimate goal of SENTRY is to inform and alert the counterdrug community to address problems at an early stage.

---

Authorizing Statute(s): PL: Pub.L. 102 - 396 9078 Name of Law: Department of Defense Appropriations Act, 1993
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	72 FR 21051	04/27/2007
30-day Notice:	Federal Register Citation:	Citation Date:
	72 FR 39449	07/18/2007
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
SENTRY/Emerging Drug Tracking System	1105-xxxx, 1105-xxxx, 1105-xxxx, 1105-xxxx	SENTRY Requirements (Exhibits) ,   SENTRY Requirements ,   SENTRY Source Identification Table ,   SENTRY User Account Table

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	300	0	0	300	0	0
Annual Time Burden (Hours)	75	0	0	75	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: New collection.

---

Annual Cost to Federal Government: $115,000

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/24/2007

---